Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies the ...

Malignant melanoma is one of the most dangerous forms of cancer. Around half of melanomas and about 7% of all other cancers ...

Signalling between neurons and tumour cells in the lung and brain promotes the growth of small-cell lung cancer. These interactions might be a therapeutic target. Read the paper: Neuronal ...

A new research perspective was published in Volume 13 of Oncoscience on June 3, 2026, titled "The dual axis of tumorigenesis: ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...

A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in ...

Newly discovered protein conformation offers a potential target for cancer drugs. Villigen, 21.07.2026 — Several types of ...

The blood–brain barrier (BBB) is a specialized vascular interface that strictly regulates the exchange of cells and molecules between the bloodstream and ...

Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against ...

Laboratory studies suggest cinnamon’s bioactive compounds can alter key cancer-related signaling pathways, but researchers caution that human trials are essential before any preventive or therapeutic ...

A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack ...